Crossmark

Construction of a target MSNs drugcarrier loaded with siRNAGLI1 and siRNASMO aim at hedgehog signal pathway and the pharmacodynamic study of drug-carriers in the treatment of leukemia stem cells

Crossref DOI link: https://doi.org/10.1007/s13346-020-00893-3

Published Online: 2022-02-03

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yuan

Cai, Rui

Li, HaiJun

Duan, Yu

Zhang, Yan

Jing, Wei

Lv, ShaoGang

Chu, Xi

Cao, Zheng

Yang, Lei

Ming, Liang
License Information

Text and Data Mining valid from 2022-02-03

Version of Record valid from 2022-02-03
More Information

Article History

Accepted: 26 December 2020

First Online: 3 February 2022

Compliance with ethical standards

:

: All the listed authors have approved the manuscript and its submission and the authors have declared that no conflict of interest exists.

: No animal or human studies were carried out by the authors for this article.

: The copyright to the English-language article is transferred to Drug Delivery and Translational Research effective if and when the article is accepted for publication.

Document is current

Any future updates will be listed below